Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Suspended × obinutuzumab × Clear all

Phase

Status

Completed 25 Terminated 12 Recruiting 9 Active not recruiting 9 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1

Interventions

Specimen Handling 14 Cyclophosphamide 9 Biopsy 7 Magnetic Resonance Spectroscopy 6 venetoclax 4 Etoposide 4 fludarabine phosphate 3 fludarabine 3 aldesleukin 3 X-Rays 3 Tacrolimus 3 Paclitaxel 3 Interleukin-2 3 Carboplatin 3 Azacitidine 3 zanubrutinib 2 prednylidene 2 durvalumab 2 deltacortene 2 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Protein Subunit Vaccines 2 Prednisone 2 Nivolumab 2 Melphalan 2 Leukapheresis 2 Injections 2 E 7107 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡